Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mTLIP vs ESPB for Pain Management in Lumbar Spinal Surgery
NCT04189341Withdrawn
- Sponsor
- Istanbul Medipol University
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Istanbul Medipol University. Primary endpoint: Opioid consumption at 48 hours. Planned start Jan 2020; status: withdrawn.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04189341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189341.